IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study

INTRODUCTION: IgG anti-apolipoprotein A-1 (IgG anti-apoA-1) antibodies are present in patients with systemic lupus erythematosus (SLE) and may link inflammatory disease activity and the increased risk of developing atherosclerosis and cardiovascular disease (CVD) in these patients. We carried out a...

Descripción completa

Detalles Bibliográficos
Autores principales: Croca, Sara, Bassett, Paul, Chambers, Sharon, Davari, Maria, Alber, Karim Fouad, Leach, Oliver, Ioannou, Yiannis, Giles, Ian, Isenberg, David, Rahman, Anisur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354753/
https://www.ncbi.nlm.nih.gov/pubmed/25890187
http://dx.doi.org/10.1186/s13075-015-0539-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354753/
https://www.ncbi.nlm.nih.gov/pubmed/25890187
http://dx.doi.org/10.1186/s13075-015-0539-z

Ejemplares similares